Achieve Life Sciences, Inc. Increase (Decrease) in Restructuring Reserve
Achieve Life Sciences, Inc. (ACHV) reported Increase (Decrease) in Restructuring Reserve of -$194.00 thousand for the 12-month period ending 2015-12-31, per its 10-K filed 2017-02-23.
Discontinued › Cash Flow › Operating Activities
us-gaap:IncreaseDecreaseInRestructuringReserve · last filed 2017-02-23
- Achieve Life Sciences, Inc. increase (decrease) in restructuring reserve for the quarter ending 2015-12-31 was $0.00.
- Achieve Life Sciences, Inc. increase (decrease) in restructuring reserve for the quarter ending 2015-09-30 was $0.00.
- Achieve Life Sciences, Inc. increase (decrease) in restructuring reserve for the quarter ending 2015-06-30 was $0.00.
- Achieve Life Sciences, Inc. increase (decrease) in restructuring reserve for the quarter ending 2015-03-31 was -$194.00K.
- Achieve Life Sciences, Inc. increase (decrease) in restructuring reserve for fiscal 2015 was -$194.00K.
- Achieve Life Sciences, Inc. increase (decrease) in restructuring reserve for fiscal 2014 was -$785.00K.
- Achieve Life Sciences, Inc. increase (decrease) in restructuring reserve for fiscal 2013 was -$680.00K.
- Achieve Life Sciences, Inc. increase (decrease) in restructuring reserve for fiscal 2012 was -$795.00K.
| Period end | Increase (Decrease) in Restructuring Reserve 3 month | Increase (Decrease) in Restructuring Reserve 6 month | Increase (Decrease) in Restructuring Reserve 9 month | Increase (Decrease) in Restructuring Reserve 12 month |
|---|---|---|---|---|
| 2015-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2017-02-23 | $0.00 derived: sum of 2 quarters · filed 2017-02-23 | $0.00 derived: sum of 3 quarters · filed 2017-02-23 | -$194.00K 10-K · filed 2017-02-23 |
| 2015-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2016-11-10 | $0.00 derived: sum of 2 quarters · filed 2016-11-10 | -$194.00K 10-Q · filed 2016-11-10 | -$397.00K derived: sum of 4 quarters · filed 2017-02-23 |
| 2015-06-30 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2016-08-04 | -$194.00K 10-Q · filed 2016-08-04 | -$397.00K derived: sum of 3 quarters · filed 2017-02-23 | -$596.00K derived: sum of 4 quarters · filed 2017-02-23 |
| 2015-03-31 | -$194.00K 10-Q · filed 2016-05-12 | -$397.00K derived: sum of 2 quarters · filed 2017-02-23 | -$596.00K derived: sum of 3 quarters · filed 2017-02-23 | -$790.00K derived: sum of 4 quarters · filed 2017-02-23 |
| 2014-12-31 | -$203.00K derived: 10-K 12 month − 10-Q 9 month · filed 2017-02-23 | -$402.00K derived: sum of 2 quarters · filed 2017-02-23 | -$596.00K derived: sum of 3 quarters · filed 2017-02-23 | -$785.00K 10-K · filed 2017-02-23 |
| 2014-09-30 | -$199.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2015-11-12 | -$393.00K derived: sum of 2 quarters · filed 2015-11-12 | -$582.00K 10-Q · filed 2015-11-12 | -$758.00K derived: sum of 4 quarters · filed 2016-03-09 |
| 2014-06-30 | -$194.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2015-08-13 | -$383.00K 10-Q · filed 2015-08-13 | -$559.00K derived: sum of 3 quarters · filed 2016-03-09 | -$732.00K derived: sum of 4 quarters · filed 2016-03-09 |
| 2014-03-31 | -$189.00K 10-Q · filed 2015-05-14 | -$365.00K derived: sum of 2 quarters · filed 2016-03-09 | -$538.00K derived: sum of 3 quarters · filed 2016-03-09 | -$705.00K derived: sum of 4 quarters · filed 2016-03-09 |
| 2013-12-31 | -$176.00K derived: 10-K 12 month − 10-Q 9 month · filed 2016-03-09 | -$349.00K derived: sum of 2 quarters · filed 2016-03-09 | -$516.00K derived: sum of 3 quarters · filed 2016-03-09 | -$680.00K 10-K · filed 2016-03-09 |
| 2013-09-30 | -$173.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2014-10-30 | -$340.00K derived: sum of 2 quarters · filed 2014-10-30 | -$504.00K 10-Q · filed 2014-10-30 | -$710.00K derived: sum of 4 quarters · filed 2015-03-26 |
| 2013-06-30 | -$167.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2014-08-07 | -$331.00K 10-Q · filed 2014-08-07 | -$537.00K derived: sum of 3 quarters · filed 2015-03-26 | |
| 2013-03-31 | -$164.00K 10-Q · filed 2014-04-30 | -$370.00K derived: sum of 2 quarters · filed 2015-03-26 | ||
| 2012-12-31 | -$206.00K derived: 10-K 12 month − 10-Q 9 month · filed 2015-03-26 | -$795.00K 10-K · filed 2015-03-26 | ||
| 2012-09-30 | -$589.00K 10-Q · filed 2013-11-07 | |||
| 2011-12-31 | -$407.00K 10-K · filed 2014-03-11 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| QuidelOrtho Corp (QDEL) | United States | $0.733B | -0.90 |
| Alpha Teknova, Inc. (TKNO) | United States | $0.500B | -18.12 |
| MYRIAD GENETICS INC (MYGN) | United States | $0.397B | -4.84 |
| Insight Molecular Diagnostics Inc. (IMDX) | United States | $0.129B | -3.90 |
| IMMUCELL CORP /DE/ (ICCC) | United States | $0.091B | 116.10 |
| BIOMERICA INC (BMRA) | United States | $0.011B | |
| Q/C TECHNOLOGIES, INC. (QCLS) | United States | $0.008B | -1.93 |
| Cardio Diagnostics Holdings, Inc. (CDIO) | United States | $0.006B | |
| VOLITIONRX LTD (VNRX) | $0.003B | -0.64 | |
| Intellia Therapeutics, Inc. (NTLA) | United States | $1.705B | -5.92 |